Tech Center 3700 • Art Units: 3772 3786 3792
This examiner grants 46% of resolved cases
Caitlin Ann Carreiro is an examiner in Tech Center 3700 and Art Unit 3772. She has 695 resolved cases. The allowance rate for these cases is 46.0%, and the interview lift is 38.4%. This 38.4% lift indicates that interviews are associated with a significant increase in the probability of allowance. Practitioners can use the 38.4% lift to improve their chances of securing a grant in her docket.
The median days to allowance is 1408 for the 695 resolved cases. This 1408-day figure provides a timeline for applications that reach a grant. The 38.4% interview lift suggests that direct communication is a useful tool for reaching the 46.0% allowance rate. With 695 cases resolved, these metrics offer a basis for managing expectations regarding both the outcome and the 1408-day duration of prosecution in Art Unit 3772.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18687845 | Nonwoven with Bio Particles and Methods of Making the Same | Final Rejection | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY |
| 17917306 | MEDICAL ADHESIVE ARTICLES HAVING A LOW EFFECTIVE MODULUS OF ELASTICITY | Non-Final OA | Solventum Intellectual Properties Company |
| 19205890 | HEAD SUPPORT AND METHOD FOR USE OF THE HEAD SUPPORT FOR POSITIONING A PATIENT RELATIVE TO A SURGICAL FRAME | Non-Final OA | Warsaw Orthopedic, Inc. |
| 17911496 | Barrier Mask | Final Rejection | Kimberly-Clark Worldwide, Inc. |
| 18698986 | DEVICE FOR COVERING AN AREA OF THE BODY OF A PATIENT | Final Rejection | Cook Medical Technologies LLC |
| 17747480 | Multi-Layer Wound Care Device Having Absorption and Fluid Transfer Properties | Non-Final OA | Milliken & Company |
| 19108416 | ORAL USE OF AN IN-MOUTH WEARABLE DEVICE IN THE TREATMENT OF DYSPHAGIA | Final Rejection | NATIONAL UNIVERSITY CORPORATION TOKYO MEDICAL AND DENTAL UNIVERSITY |
| 18424612 | MEDICAL BANDAGE | Non-Final OA | Changzhou Beifei Non-Woven Fabric Technology Co., Ltd. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy